These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35232885)

  • 1. SNMMI Reacts to CMS Coverage Decision.
    J Nucl Med; 2022 Mar; 63(3):12N. PubMed ID: 35232885
    [No Abstract]   [Full Text] [Related]  

  • 2. Statutory Authority for Medicare Coverage Decisions-CMS Is an Independent Federal Agency.
    Crosson FX; Redberg RF
    JAMA Intern Med; 2023 Sep; 183(9):910-912. PubMed ID: 37505506
    [No Abstract]   [Full Text] [Related]  

  • 3. CMS Coverage With Evidence Development-Challenges and Opportunities for Improvement.
    Phillips KA
    JAMA Health Forum; 2022 Sep; 3(9):e223061. PubMed ID: 36218935
    [No Abstract]   [Full Text] [Related]  

  • 4. CMS Proposes Medicare Coverage Policy for Monoclonal Antibody-Based Alzheimer Treatment.
    J Nucl Med; 2022 Mar; 63(3):12N. PubMed ID: 35232884
    [No Abstract]   [Full Text] [Related]  

  • 5. Bariatric surgery complications before vs after implementation of a national policy restricting coverage to centers of excellence.
    Dimick JB; Nicholas LH; Ryan AM; Thumma JR; Birkmeyer JD
    JAMA; 2013 Feb; 309(8):792-9. PubMed ID: 23443442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
    Schulman KA; Greicius MD; Richman B
    JAMA; 2021 Aug; 326(5):383-384. PubMed ID: 34279572
    [No Abstract]   [Full Text] [Related]  

  • 7. Should CMS cover lung cancer screening for the fully informed patient?
    Volk RJ; Hawk E; Bevers TB
    JAMA; 2014 Sep; 312(12):1193-4. PubMed ID: 25247511
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare 101: Navigating the Rules for Coverage and Benefits in Clinical Practice.
    Hansmann KJ
    Fam Pract Manag; 2022; 29(1):21-25. PubMed ID: 35014774
    [No Abstract]   [Full Text] [Related]  

  • 9. Data Characterization of Medicaid: Legacy and New Data Formats in the CMS Virtual Research Data Center.
    Williams N; Mayer CS; Huser V
    AMIA Jt Summits Transl Sci Proc; 2021; 2021():644-652. PubMed ID: 34457180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMS to test concurrent coverage of hospice and curative care.
    Evans M
    Mod Healthc; 2015 Jul; 45(30):10-1. PubMed ID: 26510274
    [No Abstract]   [Full Text] [Related]  

  • 11. Coverage of Transvenous Pulmonary Embolectomy - Medicare's Missed Opportunity for Evidence Generation.
    Dhruva SS; Redberg RF
    N Engl J Med; 2022 Mar; 386(10):904-906. PubMed ID: 34788505
    [No Abstract]   [Full Text] [Related]  

  • 12. CMS proposes appeals process for Medicare coverage decisions.
    Patient Acc; 2002 Oct; 25(10):1, 3. PubMed ID: 12389394
    [No Abstract]   [Full Text] [Related]  

  • 13. Centers for Medicare and Medicaid Services Positive Airway Pressure Adherence Criteria May Limit Treatment to Many Medicare Beneficiaries.
    Naik S; Al-Halawani M; Kreinin I; Kryger M
    J Clin Sleep Med; 2019 Feb; 15(2):245-251. PubMed ID: 30736874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare Coverage of Aducanumab - Implications for State Budgets.
    Sachs RE; Bagley N
    N Engl J Med; 2021 Nov; 385(22):2019-2021. PubMed ID: 34797617
    [No Abstract]   [Full Text] [Related]  

  • 15. CMS: Medicare drug formularies to cover most HIV drugs.
    AIDS Policy Law; 2005 Aug; 20(15):2. PubMed ID: 16136681
    [No Abstract]   [Full Text] [Related]  

  • 16. New CMS medicare coverage decision memorandum supervised exercise therapy for symptomatic PAD.
    Sollins HL
    Geriatr Nurs; 2017; 38(4):354-355. PubMed ID: 28687368
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare's New Device-Coverage Pathway - Breakthrough or Breakdown?
    Rathi VK; Johnston JL; Ross JS; Dhruva SS
    N Engl J Med; 2021 Mar; 384(12):e43. PubMed ID: 33691059
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare's national coverage decisions for technologies, 1999-2007.
    Neumann PJ; Kamae MS; Palmer JA
    Health Aff (Millwood); 2008; 27(6):1620-31. PubMed ID: 18997221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare's national coverage decisions, 1999-2003: quality of evidence and review times.
    Neumann PJ; Divi N; Beinfeld MT; Levine BS; Keenan PS; Halpern EF; Gazelle GS
    Health Aff (Millwood); 2005; 24(1):243-54. PubMed ID: 15647237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Centers for Medicare and Medicaid Services (CMS) COVID-19 Brief: Unsettling Racial and Ethnic Health Disparities.
    Adashi EY; Gruppuso PA
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S13-S15. PubMed ID: 33622810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.